These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6182310)
1. Evaluation of hypotensive mechanisms of captopril in addition to its inhibition of the converting enzyme in spontaneously hypertensive rats. Mikami H; Ogihara T; Ohde H; Naka T; Kumahara Y Jpn Circ J; 1982 Nov; 46(11):1154-8. PubMed ID: 6182310 [TBL] [Abstract][Full Text] [Related]
2. Suppression of hypotensive responses of captopril and enalapril by the kallikrein inhibitor aprotinin in spontaneously hypertensive rats. Sharma JN; Amrah SS; Noor AR Pharmacology; 1995 Jun; 50(6):363-9. PubMed ID: 7568335 [TBL] [Abstract][Full Text] [Related]
3. Different mechanisms maintaining high blood pressure in chronic one-kidney, one-clip, and two-kidney, one-clip hypertensive rats. Hashimoto H; Hiwada K; Kokubu T Clin Exp Hypertens A; 1983; 5(3):429-45. PubMed ID: 6188560 [TBL] [Abstract][Full Text] [Related]
4. Indomethacin does not attenuate the hypotensive effect of captopril, a converting enzyme inhibitor in Goldblatt hypertensive rats. Omata K; Otsuka Y; Chiba S; Itoh T; Gotoh T; Imai Y; Sakurai Y; Satoh M; Haruyama T; Hiwatari M; Satoh K; Kaitoh A; Abe K; Yoshinaga K Tohoku J Exp Med; 1981 May; 134(1):9-19. PubMed ID: 7031986 [No Abstract] [Full Text] [Related]
5. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Cachofeiro V; Sakakibara T; Nasjletti A Hypertension; 1992 Feb; 19(2):138-45. PubMed ID: 1737647 [TBL] [Abstract][Full Text] [Related]
6. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats. Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314 [TBL] [Abstract][Full Text] [Related]
7. Altered blood pressure and renin responses to converting enzyme inhibition after aprotinin-induced kallikrein-kinin-system blockade. Overlack A; Stumpe KO; Kühnert M; Heck I Clin Sci (Lond); 1980 Dec; 59 Suppl 6():129s-132s. PubMed ID: 6160938 [TBL] [Abstract][Full Text] [Related]
8. Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment. Mullane KM; Moncada S Eur J Pharmacol; 1980 Sep; 66(4):355-65. PubMed ID: 6998710 [TBL] [Abstract][Full Text] [Related]
9. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin. Miyamori I; Brown MJ; Dollery CT Clin Exp Hypertens (1978); 1980; 2(6):935-45. PubMed ID: 7004806 [TBL] [Abstract][Full Text] [Related]
10. Role of prostaglandins in the renal response to angiotensin-converting enzyme inhibition and renal artery occlusion. van Leeuwen BH; Anderson WP; Johnston CI J Cardiovasc Pharmacol; 1983; 5(5):883-8. PubMed ID: 6195481 [TBL] [Abstract][Full Text] [Related]
11. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats. Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184 [TBL] [Abstract][Full Text] [Related]
12. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics. Chan PS; Ronsberg MA; Cervoni P Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system. Filep J; Rigter B; Földes-Filep E J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174 [TBL] [Abstract][Full Text] [Related]
14. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats. Unger T; Kaufmann-Bühler I; Schölkens B; Ganten D Eur J Pharmacol; 1981 Apr; 70(4):467-78. PubMed ID: 6263638 [TBL] [Abstract][Full Text] [Related]
15. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients. Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347 [TBL] [Abstract][Full Text] [Related]
16. Dissociation between in vivo and in vitro measurements of converting enzyme activity after chronic oral treatment with captopril in rats. Unger T; Hübner D; Schüll B; Yukimura T; Rascher W; Lang RE; Ganten D Am J Cardiol; 1982 Apr; 49(6):1530-2. PubMed ID: 6280482 [TBL] [Abstract][Full Text] [Related]
17. Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition. Silberbauer K; Stanek B; Templ H Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):87S-93S. PubMed ID: 6753910 [TBL] [Abstract][Full Text] [Related]
18. Failure of aspirin to modify the hypotensive action of captopril in spontaneously hypertensive rats. DiNicolantonio R; Dusting GJ; Hutchinson JS; Mendelsohn FA Clin Exp Pharmacol Physiol; 1981 Jul; 8(4):345-9. PubMed ID: 7030543 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of bradykinin by captopril during suppression of prostacyclin synthesis. Vandongen R; Tunney A; Barden A; Mahoney D Hypertension; 1982; 4(5):642-5. PubMed ID: 7049919 [TBL] [Abstract][Full Text] [Related]
20. The kallikrein-kinin system in blood pressure homeostasis. Lee TC; Kushiro T; Gassia JP; Girolami JP; Lupu AN; Maxwell MH Clin Sci (Lond); 1979 Dec; 57 Suppl 5():255s-258s. PubMed ID: 94277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]